Ajanta Pharma Limited
AJANTPHARM
Pozycja w akcjach
#3690
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Cena akcji
$36.39
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$4.55B
Zmiana (1 dzień)
-0.59%
Zmiana (1 rok)
31.26%
Kraj
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategoria
Healthcare
EPS dla Ajanta Pharma Limited (AJANTPHARM)
EPS na dzień June 2026 TTM: $1.00
Według najnowszych raportów finansowych i ceny akcji firmy Ajanta Pharma Limited, obecny EPS (TTM) wynosi $1.00. Na koniec roku 2024 firma miała EPS w wysokości $0.78, wzrost w porównaniu do do EPS z roku 2023, który wynosił $0.56.
Historia EPS dla Ajanta Pharma Limited od 2005 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $1.00 | 16.57% |
| 2025 | $0.86 | 10.64% |
| 2024 | $0.78 | 39.22% |
| 2023 | $0.56 | -22.89% |
| 2022 | $0.72 | 5.91% |
| 2021 | $0.68 | 44.17% |
| 2020 | $0.47 | 12.34% |
| 2019 | $0.42 | -22.56% |
| 2018 | $0.55 | -7.91% |
| 2017 | $0.59 | 24.55% |
| 2016 | $0.48 | 26.28% |
| 2015 | $0.38 | 27.12% |
| 2014 | $0.30 | 89.08% |
| 2013 | $0.16 | 35.47% |
| 2012 | $0.12 | 33.80% |
| 2011 | $0.09 | 50.52% |
| 2010 | $0.06 | 51.05% |
| 2009 | $0.04 | -8.43% |
| 2008 | $0.04 | 62.11% |
| 2007 | $0.03 | 21.33% |
| 2006 | $0.02 | 22.67% |
| 2005 | $0.02 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -44.51% |
IN
|
